Kidney stone disease is a substantial health problem associated with significant pain, suffering, and economic costs. By the age of 70, 5% to 15% of the population will have a symptomatic episode of a stone and at least 50% of these individuals will have recurrent stone disease. Idiopathic calcium oxalate stone disease accounts for the majority of stone forming patients. It is generally accepted that idiopathic stone patients do not have dramatic anatomic, metabolic, or physiologic abnormalities. ? ? Idiopathic CaOx stone disease appears to require both supersaturation of the urine with respect to calcium and oxalate and tissue injury in the late collecting duct for crystals to attach, initiating stone development. The injury site appears to be highly localized to the site of the stone. Animal studies to date have used dramatic hyperoxaluric conditions that may have limited our ability to see the early events resulting from chronic mild hyperoxaluria as seen in idiopathic CaOx stone patients. No animal studies to date have explored the potential impact of chronic exposure of low levels of oxalate as might be seen in the idiopathic stone patients. ? ? This grant focuses on the attachment of urinary crystals to injured kidney papillary tip urothelium and the conditions and events that allow for crystal attachment. We will study long-term exposure of low to mild oxalate levels that might be associated with papillary tubular or vascular injury. The hypothesis to be tested is that CaOx crystal attachment to late collecting duct urothelium is dependent on localized injury that may originate in either the late collecting duct or in the vasculature intimately associated with the tubule crystal attachment site. We also hypothesize that chronic low levels of oxalate exposure as may be seen in idiopathic calcium oxalate stone patients may be sufficient to induce this injury. This grant proposal contains three Specific Aims to test this hypothesis. ? ? Specific Aim I: To determine if chronic exposure to oxalate levels insufficient for widespread CaOx crystal formation leads to the disruption of normal tubule physiology and the initiation of injury associated with effective urothelial crystal attachment and stone formation. ? ? Specific Aim II: To determine if tubule injury necessary for effective crystal attachment stems from oxalate-induced changes in the associated vasculature. ? ? Specific Aim III: To determine if oxalate-associated injury leading to effective CaOx crystal attachment and stone formation is exacerbated by the presence of other vascular and tubule injuries such as that associated with hypertension. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK030579-20A1
Application #
7140767
Study Section
Special Emphasis Panel (ZRG1-RUS-B (04))
Program Officer
Rasooly, Rebekah S
Project Start
1982-07-01
Project End
2011-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
20
Fiscal Year
2006
Total Cost
$258,300
Indirect Cost
Name
Medical College of Wisconsin
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Yamaguchi, Satoshi; Wiessner, John H; Hasegawa, Andrew T et al. (2005) Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions. Int J Urol 12:290-8
Newland, M Christopher; Reile, Phyllis A; Sartin, Eva A et al. (2005) Urolithiasis in rats consuming a dl bitartrate form of choline in a purified diet. Comp Med 55:354-67
Wiessner, John H; Hung, Linda Y; Mandel, Neil S (2003) Crystal attachment to injured renal collecting duct cells: influence of urine proteins and pH. Kidney Int 63:1313-20
Yamaguchi, Satoshi; Wiessner, John; Hasegawa, Andrew et al. (2002) Calcium oxalate monohydrate crystal binding substance produced from Madin-Darby canine kidney cells. Int J Urol 9:501-8
Keim, A L; Chi, M M; Moley, K H (2001) Hyperglycemia-induced apoptotic cell death in the mouse blastocyst is dependent on expression of p53. Mol Reprod Dev 60:214-24
Chi, M M; Schlein, A L; Moley, K H (2000) High insulin-like growth factor 1 (IGF-1) and insulin concentrations trigger apoptosis in the mouse blastocyst via down-regulation of the IGF-1 receptor. Endocrinology 141:4784-92
Carayannopoulos, M O; Chi, M M; Cui, Y et al. (2000) GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst. Proc Natl Acad Sci U S A 97:7313-8
Chi, M M; Pingsterhaus, J; Carayannopoulos, M et al. (2000) Decreased glucose transporter expression triggers BAX-dependent apoptosis in the murine blastocyst. J Biol Chem 275:40252-7
Chini, E N; Liang, M; Dousa, T P (1998) Differential effect of pH upon cyclic-ADP-ribose and nicotinate-adenine dinucleotide phosphate-induced Ca2+ release systems. Biochem J 335 ( Pt 3):499-504
Bigelow, M W; Wiessner, J H; Kleinman, J G et al. (1998) Calcium oxalate crystal attachment to cultured kidney epithelial cell lines. J Urol 160:1528-32

Showing the most recent 10 out of 28 publications